ADVANCED RENAL CELL CARCINOMA
Clinical trials for ADVANCED RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost: could a probiotic supercharge cancer treatment?
Disease control OngoingThis early-stage study is testing if adding a probiotic called CBM588 to standard cancer drugs (cabozantinib and nivolumab) can help patients with advanced kidney cancer. The probiotic aims to improve the mix of 'good' bacteria in the gut, which might help the body's immune syste…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New combo therapy trial offers hope for HIV patients with advanced cancers
Disease control OngoingThis is a small, early-stage safety study testing a combination of two cancer drugs, nivolumab and cabozantinib, in people living with HIV who have advanced solid tumors. The main goal is to see if the two-drug combination is safe and tolerable for this specific patient group. Re…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
New drug duo battles advanced kidney cancer in Head-to-Head trial
Disease control TerminatedThis study is testing a new combination of two immunotherapy drugs (botensilimab and balstilimab) for people newly diagnosed with advanced kidney cancer that has spread. It will compare this new combination to a standard two-drug immunotherapy treatment (ipilimumab and nivolumab)…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Michael B. Atkins, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Targeted radiation joins fight against bone pain in advanced kidney cancer
Disease control OngoingThis study is for people with advanced kidney cancer that has spread to their bones. It tests if adding a radioactive drug (radium-223) to a standard cancer pill (cabozantinib) works better than the pill alone. The main goal is to see if the combination can delay bone-related pro…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC
-
Targeted radiation bullet teams up with immune drug to fight tough kidney cancers
Disease control OngoingThis study is testing whether combining a targeted radiation drug (177Lu-girentuximab) with an immunotherapy drug (nivolumab) is safe and effective for treating advanced kidney cancer that has a specific protein (CAIX). It is for adults with clear cell kidney cancer that has spre…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC
-
Doctors track new kidney cancer drug duo in real patients
Disease control OngoingThis study is observing how well the combination of cabozantinib and nivolumab works for adults with advanced kidney cancer in real-world medical settings. Researchers are following 311 patients who have already been prescribed this two-drug treatment as their first therapy. The …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Sponsor: Ipsen • Aim: Disease control
Last updated Feb 23, 2026 14:57 UTC
-
Doctors track Real-World impact of kidney cancer drugs
Knowledge-focused OngoingThis study is observing how patients with advanced kidney cancer respond to treatment with the drug cabozantinib, either alone or combined with nivolumab, in everyday clinical practice. It involves 224 adults who are already receiving this as their first treatment. The main goal …
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Sponsor: Ipsen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:31 UTC
-
Scientists hunt Cancer's genetic blueprint to match patients with best drugs
Knowledge-focused OngoingThis study aims to understand why some cancer treatments work for certain patients but not others. Researchers will collect tumor tissue and blood samples from 156 people with advanced prostate, kidney, or bladder cancer who are about to start a new treatment. By analyzing the ge…
Matched conditions: ADVANCED RENAL CELL CARCINOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC